Turning captured CO₂ into high-value bioproducts
Jesse Hipps, Sr., CEO and Co-Founder of Aegis BioScience, Inc., leverages 40 years of expertise in industrial chemistry and materials science to convert CO₂ into high-value bioproducts. An inventor on ten U.S. patents, his career spans technical and leadership roles at industry giants including Monsanto and DuPont, complemented by extensive entrepreneurial experience.
Today, Jesse directs Aegis’s corporate strategy, commercialization, and strategic partnerships, driving algae-based carbon utilization technologies from research to commercial deployment.
Pathways to Commercial-Scale CCUS: Deployment Strategies, Risk Allocation, and Market Readiness
A panel on what it actually takes to move CCUS from demonstration to commercial scale — how projects are de-risked and financed, where policy and permitting still bite, and how emerging carbon-utilization routes turn captured CO₂ into products with their own revenue stack.
- Leveraging digitalization, automation, and artificial intelligence to enhance operational efficiency and improve commercial-scale CCUS project economics
- Navigating decarbonization challenges and federal tax policy impacts across commercial hydrogen production and storage pathways
- Evaluating commercial bankability and strategic revenue stacks to de-risk projects amidst evolving market and policy uncertainties
- Mitigating subsurface environmental risks, legacy well integrity issues, and Class VI permitting challenges through advanced numerical modeling and monitoring
- Accelerating commercialization of emerging carbon-utilization technologies through value-added product revenue streams, technology de-risking, and strategic industry-lab partnerships
Key topics and specialisms
Other Speakers at CCUS Xchange USA 2026
